BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27255940)

  • 1. Significant Improvement in Outcomes of Patients with Intrahepatic Cholangiocarcinoma after Surgery.
    Yoh T; Hatano E; Nishio T; Seo S; Taura K; Yasuchika K; Okajima H; Kaido T; Uemoto S
    World J Surg; 2016 Sep; 40(9):2229-36. PubMed ID: 27255940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular factors associated with recurrence and survival following hepatectomy in patients with intrahepatic cholangiocarcinoma: a guide to adjuvant clinical trials.
    Schiffman SC; Nowacki MR; Spencer L; McMasters KM; Scoggins CR; Martin RC
    J Surg Oncol; 2014 Feb; 109(2):98-103. PubMed ID: 24122302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment.
    Rayar M; Sulpice L; Edeline J; Garin E; Levi Sandri GB; Meunier B; Boucher E; Boudjema K
    Ann Surg Oncol; 2015 Sep; 22(9):3102-8. PubMed ID: 25623598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
    Zhou PY; Tang Z; Liu WR; Tian MX; Jin L; Jiang XF; Wang H; Tao CY; Ding ZB; Peng YF; Qiu SJ; Dai Z; Zhou J; Fan J; Shi YH
    BMC Cancer; 2017 Nov; 17(1):762. PubMed ID: 29137600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy.
    Bagante F; Gani F; Spolverato G; Xu L; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Marsh JW; Pawlik TM
    J Am Coll Surg; 2015 Dec; 221(6):1031-40.e1-4. PubMed ID: 26474514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes for Patients with Recurrent Intrahepatic Cholangiocarcinoma After Surgery.
    Park HM; Yun SP; Lee EC; Lee SD; Han SS; Kim SH; Park SJ
    Ann Surg Oncol; 2016 Dec; 23(13):4392-4400. PubMed ID: 27581609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in patients with recurrent intrahepatic cholangiocarcinoma after curative resection: A retrospective cohort study.
    Ohira M; Kobayashi T; Hashimoto M; Tazawa H; Abe T; Oshita A; Kohashi T; Irei T; Oishi K; Ohdan H;
    Int J Surg; 2018 Jun; 54(Pt A):156-162. PubMed ID: 29730072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival.
    Ercolani G; Vetrone G; Grazi GL; Aramaki O; Cescon M; Ravaioli M; Serra C; Brandi G; Pinna AD
    Ann Surg; 2010 Jul; 252(1):107-14. PubMed ID: 20531002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant transcatheter arterial chemoembolization for intrahepatic cholangiocarcinoma after curative surgery: retrospective control study.
    Shen WF; Zhong W; Liu Q; Sui CJ; Huang YQ; Yang JM
    World J Surg; 2011 Sep; 35(9):2083-91. PubMed ID: 21698503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
    Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
    Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy?
    Patel SH; Kooby DA; Staley CA; Sarmiento JM; Maithel SK
    HPB (Oxford); 2011 Sep; 13(9):605-11. PubMed ID: 21843260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral infiltration of intrahepatic cholangiocarcinoma is most prognostic after curative resection - Retrospective cohort study of 102 consecutive liver resections from a single center.
    Bartsch F; Baumgart J; Hoppe-Lotichius M; Schmidtmann I; Heinrich S; Lang H
    Int J Surg; 2018 Jul; 55():193-200. PubMed ID: 29803768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: A multi-institutional analysis.
    Reames BN; Ejaz A; Koerkamp BG; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Martel G; Marsh JW; Pawlik TM
    J Surg Oncol; 2017 Aug; 116(2):133-139. PubMed ID: 28411373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
    Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
    Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of serum γ-glutamyltransferase as a predictor of aggressive tumor behaviors and unfavorable prognosis in patients with intrahepatic cholangiocarcinoma: analysis of a large monocenter study.
    Yin X; Zheng SS; Zhang BH; Zhou Y; Chen XH; Ren ZG; Qiu SJ; Fan J
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1408-14. PubMed ID: 23839159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of Intrahepatic Cholangiocarcinomas with HBV Infection is Better than Those with Hepatolithiasis After R0 Liver Resection: A Propensity Score Matching Analysis.
    Wang Q; Li J; Lei Z; Wu D; Si A; Wang K; Wang Y; Wan X; Lau WY; Shen F
    Ann Surg Oncol; 2017 Jun; 24(6):1579-1587. PubMed ID: 28058554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma.
    Bagante F; Merath K; Squires MH; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
    J Gastrointest Surg; 2018 Mar; 22(3):477-485. PubMed ID: 29352440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
    Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
    World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.